ICREA Professor, IDIBAPS-H. Clínic. Prof. of Medicine and Director of the Liver Cancer program, Mount Sinai (New York). V. Prof. Department of Medicine, University of Barcelona.
The Official Master in Translational Medicine-MSc from the University of Barcelona offers the opportunity to gain an excellent training both in academia and research.
The master can be completed in 1 or 2 years, depending on the needs of the students. Total number of credits of the Master is 60 Credits (46,5 €/credit for Spanish citizens - 65,87€/credit for foreigners) and the official language of the Master is English. An important part of the Master is dedicated to practical training in research.
In recent years, there is a growing demand for highly qualified scientific personnel to meet the needs at public research centers as well as in the pharmaceutical industry. This increase is due to the noticeable appeal for translational research demonstrated by public/governamental institutions and the progressive interest of domestic industry by biotechnology-related activities. It is plausible that the demand for professionals skilled in translational research will grow in the coming years, both in academia and enterprise. In stark contrast to this growing demand, there are currently no undergraduate studies in our country that are professionals in this type of research. This means that graduates in health sciences in our country are at disadvantage compared to similar professionals coming from the European Community, better trained in this field. This is important to a labour market increasingly globalized, especially in the field of biomedical research. This MA aims to fill this gap in the training of highly qualified professionals in translational research.
The mission for this Master is to train a new generation of researches that are highly competitive to carry out their professional work in a field that is growing exponentially at present. For this purpose we have gathered in the current Master an outstanding set of scientists, physicians and staff from biomedical enterprises aimed to deliver state-of-the-art up-dated information in cutting-edge biomedical technologies and translational medicine.
The HANDBOOK OF TRANSLATIONAL MEDICINE is available here:
Edicions UB: http://www.publicacions.ub.edu/ficha.aspx?cod=08500
The recent advances in high-throughput technologies are revolutionizing the biomedical world. Nonetheless, basic scientists are discovering new causes of diseases, mechanisms of pathogenesis and novel drugs that are difficult to be translated into the biomedical clinical practice. This occurs in part due to the lack of a common ground of interaction between biologists, biotechnologists, geneticists, pharmacologists, physicians and biomedical companies.
We have organised this Master to provide the needed body of information to link basic knowledge and clinical needs. The information provided in this Master will fulfill the requirements needed to understand translational medicine. It certainly gathers a set of professors with experience in translational medicine, along with basic scientists and physicians devoted to clinical care.
The purpose of this Master in Translational Medicine is to provide the basis for a comprehensive understanding of all new cutting-edge technologies and discoveries in biological sciences and be able to understand their translational or clinical application in biomedicine.
* Master linked to the doctoral program “Medicine”, with Quality Mention (ANECA).
Josep M Llovet
ICREA Professor of Research, IDIBAPS - Director of the HCC Research Program, MSSM (New York) - Full Professor, Department of Medicine, Faculty of Medicine, University of Barcelona
Head of Biochemistry and Molecular Genetics Dept., Hospital Clínic, IDIBAPS - Assistant Professor, Dept. Physiological Sciences I, Faculty of Medicine, University of Barcelona
UOC - Vice President for Globalization and Cooperation
Scientific coordinator of the IDIBAPS Bioinformatics Unit - Associate Professor, Dept. Physiological Sciences I, Faculty of Medicine, University of Barcelona
Head of Pharmacology and Toxicology, Biomedical Diagnostic Center, Hospital Clínic - IDIBAPS. Adjunct medical lecturer - Dept Salut Pública, Faculty of Medicine, University of Barcelona
Director of IDIBAPS - Full Professor, Dept. Medicine, Faculty of Medicine, University of Barcelona
ISGlobal Training & Education Director - Associate Professor, Dept Pharmacology and Therapeutic Chemistry, Faculty of Medicine, University of Barcelona
Public Health Departament, Faculty of Medicine, University of Barcelona - Epidemiology and Public Health CIBER, Instituto de Salud Carlos III
Pharmacology Service, Hospital Clínic de Barcelona
Biochemistry and Molecular Genetics Dept, Hospital Clínic, IDIBAPS
Director Cancer Epigenetics & Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Associate Professor, Dept Medicina, University of Barcelona
Josep Lluis Bedini
Head of Operations Area at Hospital Clínic – Biomedical Diagnostic Center – CORE - Adjunct medical lecturer, Dept Physiological Sciences I, Faculty of Medicine, University of Barcelona
Consultor at Hospital Clínic, Biomedical Diagnostic Center, Dept Biochemistry and Molecular Genetics - Adjunct medical lecturer, Dept Physiological Sciences I, Faculty of Medicine, University of Barcelona
Director of Innovation at the Hospital Clínic Barcelona, IDIBAPS.
Director, Centro Nacional de Análisis Genómico (CNAG)
Head of the Department of Hemotherapy and Hemostasis, Hospital Clínic of Barcelona - Adjunct medical lecturer, Dept of Medicine, Faculty of Medicine, University of Barcelona
Director of Institute of Digestive and Metabolic Diseases, Hospital Clínic of Barcelona, IDIBAPS - Associate Professor, Dept of Medicine, Faculty of Medicine, University of Barcelona
IIBB-CSIC-IDIBAPS Researcher at the team Brain ischemia: Clinical and experimental studies
Core Facility Coordinator, IDIBAPS
Chief of Preventive Medicine and Epidemiology at Hospital Clínic of Barcelona - Professor of Public Health, Faculty of Medicine, University of Barcelona - Research Professor, CRESIB.
The key to any translational medicine initiative is to make sure the advances of the laboratory are finding their way into the lives of life patients
Optional Course: "Use of Laboratory Animals in Research"
(Course required for accreditation in animal experimentation. Not compulsory)
To see all the scheduled editions of this optional course and know the price, please visit the following website offered by CCIT (Centres Científics i Tecnològics de la Universitat Barcelona): CCiT
Ariadna Farré & Marta Boteller
Phone: +34 93 2279155
Facultat de Medicina (School of Medicine)
C/Casanova 143. 08036 Barcelona
Tel: (+34) 93 327 55 18